FDA Inspection
Reproductive Medicine InstituteReproductive Medicine Institute – FDA Inspection, Jan 13, 2016
Record Details
This FDA Inspection record concerns Reproductive Medicine Institute, with an inspection on January 13, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 13, 2016
- Product Type
- Biologics
View Company Profile
ID · 326e27a8-1aa1-4cb2-aa9e-41ea5e8e2ae2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 960979
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Reproductive Medicine Institute
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 8, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 18, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Reproductive Medicine Institute
- FDA Inspection 1122259 - 2020-02-05
- FDA Inspection 1045293 - 2018-02-08
- FDA Inspection 813531 - 2013-01-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.